Compare $APUS vs $SNGX | Chartloom

Compare

$APUS vs $SNGX

Apimeds Pharmaceuticals US Inc · Soligenix Inc

APUS

Apimeds Pharmaceuticals US Inc

SNGX

Soligenix Inc

Compare $APUS vs $SNGX

Comparing Apimeds Pharmaceuticals US Inc and Soligenix Inc

APUSApimeds Pharmaceuticals US Inc

SNGXSoligenix Inc

APUSApimeds Pharmaceuticals US Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.8%

52W performance

-75.9%

FCF yield

-70.6%

SNGXSoligenix Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.4%

52W performance

-79.9%

FCF yield

-180.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APUS

SNGX

Detailed metrics comparison

APUS

Apimeds Pharmaceuticals US Inc

SNGX

Soligenix Inc

Market Cap

APUS$8M

SNGX$5M

Enterprise Value

APUS$22M

SNGX$-4M

Price

APUS$5.02

SNGX$0.36

P/E Ratio

APUSN/A

SNGXN/A

P/S Ratio

APUS0.00x

SNGX16.09x

EV/Sales

APUS0.00x

SNGX-3.76x

EV/EBITDA

APUS0.00x

SNGX-1.54x

P/B Ratio

APUS0.05x

SNGX1.20x

P/FCF Ratio

APUSN/A

SNGXN/A

EV/FCF

APUS-4.06x

SNGX0.45x

PEG Ratio

APUSN/A

SNGXN/A

Forward P/E (NTM)

APUSN/A

SNGXN/A

Forward P/S (NTM)

APUSN/A

SNGXN/A

Revenue (TTM)

APUS$0

SNGX$0

Revenue Growth (YoY)

APUSN/A

SNGXN/A

Forward Rev Growth

APUS0.0%

SNGX0.0%

Gross Margin (TTM)

APUS0.0%

SNGX8.8%

Operating Margin (TTM)

APUS0.0%

SNGX0.0%

EBITDA Margin (TTM)

APUS0.0%

SNGX0.0%

Net Margin (TTM)

APUS0.0%

SNGX0.0%

FCF Margin (TTM)

APUSN/A

SNGXN/A

Net Income (TTM)

APUS$-58M

SNGX$-10M

FCF (TTM)

APUS$-5M

SNGX$-10M

EPS (TTM)

APUS-$33.95

SNGX-$0.64

ROE (TTM)

APUS-5898.0%

SNGX-18102.0%

ROA (TTM)

APUS-5261.0%

SNGX-10792.0%

ROIC (TTM)

APUS-5458.0%

SNGX-18102.0%

Cash

APUS$278K

SNGX$10M

Debt

APUS$14M

SNGX$0

Net Cash/Debt

APUS$-14M

SNGX$10M

Current Ratio (TTM)

APUS0.51x

SNGX2.77x

Quick Ratio (TTM)

APUS0.40x

SNGX2.67x

Debt/Equity (TTM)

APUS0.14x

SNGX0.00x

Debt/Assets (TTM)

APUS0.0%

SNGX0.0%

Interest Coverage (TTM)

APUSN/A

SNGXN/A

Net Debt/EBITDA (TTM)

APUS0.00x

SNGX0.00x

Beta

APUS2.60

SNGX2.15

52W Performance

APUS-75.9%

SNGX-79.9%

YTD Performance

APUS-69.8%

SNGX-74.4%

% from 52W High

APUS-91.6%

SNGX-81.5%

% from 52W Low

APUS232.5%

SNGX29.9%

Asset Turnover (TTM)

APUS0.00x

SNGX0.05x

FCF Yield (TTM)

APUS-70.6%

SNGX-180.8%

Earnings Yield (TTM)

APUS-767.4%

SNGX-190.0%

Dividend Yield (TTM)

APUSN/A

SNGXN/A

Rule of 40

APUS0.0

SNGX0.0

EV/GP/RG

APUSN/A

SNGXN/A

Ticker research

View APUS research View SNGX research

Metric	APUS Apimeds Pharmaceuticals US Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$8M	$5M
Enterprise Value	$22M	$-4M
Price	$5.02	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.09x
EV/Sales	0.00x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.05x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.06x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-10M
FCF (TTM)	$-5M	$-10M
EPS (TTM)	-$33.95	-$0.64
ROE (TTM)	-5898.0%	-18102.0%
ROA (TTM)	-5261.0%	-10792.0%
ROIC (TTM)	-5458.0%	-18102.0%
Financial Health
Cash	$278K	$10M
Debt	$14M	$0
Net Cash/Debt	$-14M	$10M
Current Ratio (TTM)	0.51x	2.77x
Quick Ratio (TTM)	0.40x	2.67x
Debt/Equity (TTM)	0.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	2.15
52W Performance	-75.9%	-79.9%
YTD Performance	-69.8%	-74.4%
% from 52W High	-91.6%	-81.5%
% from 52W Low	232.5%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-70.6%	-180.8%
Earnings Yield (TTM)	-767.4%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APUS research	View SNGX research

Valuation

P/S Ratio

APUS

0.00x

SNGX

16.09x

EV/FCF

APUS

-4.06x

SNGX

0.45x

Growth & revenue

Forward Revenue Growth

APUS

0.0%

SNGX

0.0%

Profitability & performance

Gross Margin

SNGX

8.8%

APUS

0.0%

ROE

APUS

-5898.0%

SNGX

-18102.0%

FCF Yield %

APUS

-70.6%

SNGX

-180.8%

52-Week Performance

APUS

-75.9%

SNGX

-79.9%

Detailed metrics comparison

APUS

Apimeds Pharmaceuticals US Inc

SNGX

Soligenix Inc

Market Cap

APUS$8M

SNGX$5M

Enterprise Value

APUS$22M

SNGX$-4M

Price

APUS$5.02

SNGX$0.36

P/E Ratio

APUSN/A

SNGXN/A

P/S Ratio

APUS0.00x

SNGX16.09x

EV/Sales

APUS0.00x

SNGX-3.76x

EV/EBITDA

APUS0.00x

SNGX-1.54x

P/B Ratio

APUS0.05x

SNGX1.20x

P/FCF Ratio

APUSN/A

SNGXN/A

EV/FCF

APUS-4.06x

SNGX0.45x

PEG Ratio

APUSN/A

SNGXN/A

Forward P/E (NTM)

APUSN/A

SNGXN/A

Forward P/S (NTM)

APUSN/A

SNGXN/A

Revenue (TTM)

APUS$0

SNGX$0

Revenue Growth (YoY)

APUSN/A

SNGXN/A

Forward Rev Growth

APUS0.0%

SNGX0.0%

Gross Margin (TTM)

APUS0.0%

SNGX8.8%

Operating Margin (TTM)

APUS0.0%

SNGX0.0%

EBITDA Margin (TTM)

APUS0.0%

SNGX0.0%

Net Margin (TTM)

APUS0.0%

SNGX0.0%

FCF Margin (TTM)

APUSN/A

SNGXN/A

Net Income (TTM)

APUS$-58M

SNGX$-10M

FCF (TTM)

APUS$-5M

SNGX$-10M

EPS (TTM)

APUS-$33.95

SNGX-$0.64

ROE (TTM)

APUS-5898.0%

SNGX-18102.0%

ROA (TTM)

APUS-5261.0%

SNGX-10792.0%

ROIC (TTM)

APUS-5458.0%

SNGX-18102.0%

Cash

APUS$278K

SNGX$10M

Debt

APUS$14M

SNGX$0

Net Cash/Debt

APUS$-14M

SNGX$10M

Current Ratio (TTM)

APUS0.51x

SNGX2.77x

Quick Ratio (TTM)

APUS0.40x

SNGX2.67x

Debt/Equity (TTM)

APUS0.14x

SNGX0.00x

Debt/Assets (TTM)

APUS0.0%

SNGX0.0%

Interest Coverage (TTM)

APUSN/A

SNGXN/A

Net Debt/EBITDA (TTM)

APUS0.00x

SNGX0.00x

Beta

APUS2.60

SNGX2.15

52W Performance

APUS-75.9%

SNGX-79.9%

YTD Performance

APUS-69.8%

SNGX-74.4%

% from 52W High

APUS-91.6%

SNGX-81.5%

% from 52W Low

APUS232.5%

SNGX29.9%

Asset Turnover (TTM)

APUS0.00x

SNGX0.05x

FCF Yield (TTM)

APUS-70.6%

SNGX-180.8%

Earnings Yield (TTM)

APUS-767.4%

SNGX-190.0%

Dividend Yield (TTM)

APUSN/A

SNGXN/A

Rule of 40

APUS0.0

SNGX0.0

EV/GP/RG

APUSN/A

SNGXN/A

Ticker research

View APUS research View SNGX research

Metric	APUS Apimeds Pharmaceuticals US Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$8M	$5M
Enterprise Value	$22M	$-4M
Price	$5.02	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.09x
EV/Sales	0.00x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.05x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.06x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-10M
FCF (TTM)	$-5M	$-10M
EPS (TTM)	-$33.95	-$0.64
ROE (TTM)	-5898.0%	-18102.0%
ROA (TTM)	-5261.0%	-10792.0%
ROIC (TTM)	-5458.0%	-18102.0%
Financial Health
Cash	$278K	$10M
Debt	$14M	$0
Net Cash/Debt	$-14M	$10M
Current Ratio (TTM)	0.51x	2.77x
Quick Ratio (TTM)	0.40x	2.67x
Debt/Equity (TTM)	0.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	2.15
52W Performance	-75.9%	-79.9%
YTD Performance	-69.8%	-74.4%
% from 52W High	-91.6%	-81.5%
% from 52W Low	232.5%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-70.6%	-180.8%
Earnings Yield (TTM)	-767.4%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APUS research	View SNGX research